Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spectral AI (MDAI) Share-based Compensation (2022 - 2026)

Spectral AI posted quarterly Share-based Compensation of $183000.0 for Q1 2026, down 8.5% year-on-year from $200000.0 in Q1 2025, and down 14.88% on a QoQ basis from $215000.0 in Q4 2025.

Spectral AI (MDAI) has 5 years of Share-based Compensation data on file, last reported at $183000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Share-based Compensation fell 8.5% year-over-year to $183000.0; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 12.73% YoY), and the FY2025 full-year result was $1.1 million, up 8.04% from the prior year.
  • Share-based Compensation for Q1 2026 stood at $183000.0, down from $215000.0 in the prior quarter.
  • Across five years, Share-based Compensation topped out at $400000.0 in Q2 2023 and bottomed at $174000.0 in Q4 2024.
  • The 5-year median for Share-based Compensation is $281000.0 (2022), against an average of $273600.0.
  • The widest annual swing landed in 2023, when Share-based Compensation jumped 50.0%; it then sank 35.07% in 2024.
  • A 5-year view of Share-based Compensation shows it stood at $281000.0 in 2022, then fell by 4.63% to $268000.0 in 2023, then tumbled by 35.07% to $174000.0 in 2024, then increased by 23.56% to $215000.0 in 2025, then slipped by 14.88% to $183000.0 in 2026.
  • The last three Share-based Compensation figures came in at $183000.0 (Q1 2026), $215000.0 (Q4 2025), and $300000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 317.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 87.00 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 94.00 Mn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 83.00 Mn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 45.40 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 43.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 35.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 12.90 Mn
10 Spectral AI 64.47 Mn 52.81 Mn 2.03 Mn 183,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 183,000.00
Mar 31, 2026 183,000.00
Dec 31, 2025 215,000.00
Dec 31, 2025 215,000.00
Sep 30, 2025 300,000.00
Sep 30, 2025 300,000.00
Jun 30, 2025 400,000.00
Jun 30, 2025 400,000.00
Mar 31, 2025 200,000.00
Mar 31, 2025 200,000.00
Dec 31, 2024 174,000.00
Dec 31, 2024 174,000.00
Sep 30, 2024 200,000.00
Sep 30, 2024 200,000.00
Jun 30, 2024 400,000.00
Jun 30, 2024 400,000.00
Mar 31, 2024 283,000.00
Mar 31, 2024 283,000.00
Dec 31, 2023 268,000.00
Dec 31, 2023 268,000.00
Sep 30, 2023 300,000.00
Sep 30, 2023 300,000.00
Jun 30, 2023 400,000.00
Jun 30, 2023 400,000.00
Mar 31, 2023 300,000.00
Mar 31, 2023 300,000.00
Dec 31, 2022 281,000.00
Dec 31, 2022 281,000.00
Sep 30, 2022 200,000.00
Sep 30, 2022 200,000.00